Literature DB >> 25159583

A study on proliferation and gene expression in normal human urothelial cells in culture.

Clara Ibel Chamorro1, Said Zeiai, Gisela Reinfeldt Engberg, David Brodin, Agneta Nordenskjöld, Magdalena Fossum.   

Abstract

Cultured human urothelial cells can be used in tissue engineering for reconstruction of urothelial defects. For safety reasons, a fine characterization of the cells is required before use in reconstructive surgery. For these reasons, we aimed to characterize the effect of in vitro propagation of urothelial cells on gene expression and proliferative capacity. Gene expression of urothelial cells in passage two and eight was captured by using a microarray chip covering the whole human genome. To find relationships in biological functions and pathways, differentially regulated genes were subjected to pathway analysis using the WEB-based Gene Set Analysis Toolkit (WebGestalt). Proliferative capacity was tested with population doubling time, efficiency in colony formation assays, and immunocytochemistry. In addition, senescence markers were evaluated. Bioinformatics analysis revealed gene expression profile differences. Downregulated genes at passage eight clustered in biological pathways of cell cycle and DNA repair processes; upregulated genes had no obvious association to any specific biological function or pathway according to WebGestalt analysis, but individual genes with extracellular matrix, apoptosis, and cell morphology. Data were supported by reverse transcription-polymerase chain reaction (RT-PCR) and in vitro growth experiments. Passage two urothelial cells had higher efficiency in colony formation and lower population doubling time. An increase in senescence markers was detected at passage eight. We conclude that pretransplantation quality controls are important and, for reconstructive purposes, cells should be transplanted back to the patient as soon as possible to procure good proliferative capacity also after transplantation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25159583     DOI: 10.1089/ten.TEA.2014.0175

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  3 in total

1.  Liuwei Dihuang Pill () Treats Postmenopausal Osteoporosis with Shen (Kidney) Yin Deficiency via Janus Kinase/Signal Transducer and Activator of Transcription Signal Pathway by Up-regulating Cardiotrophin-Like Cytokine Factor 1 Expression.

Authors:  Ji-Rong Ge; Li-Hua Xie; Juan Chen; Sheng-Qiang Li; Hui-Juan Xu; Yu-Lian Lai; Long-Long Qiu; Chen-Bo Ni
Journal:  Chin J Integr Med       Date:  2016-12-27       Impact factor: 1.978

Review 2.  Regenerative and engineered options for urethroplasty.

Authors:  Filippo Pederzoli; Gregory Joice; Andrea Salonia; Trinity J Bivalacqua; Nikolai A Sopko
Journal:  Nat Rev Urol       Date:  2019-06-06       Impact factor: 14.432

3.  Expansion of Submucosal Bladder Wall Tissue In Vitro and In Vivo.

Authors:  Gisela Reinfeldt Engberg; Clara Ibel Chamorro; Agneta Nordenskjöld; Magdalena Fossum
Journal:  Biomed Res Int       Date:  2016-09-29       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.